Récepteur TAM
Les inhibiteurs des récepteurs TAM ciblent la famille de récepteurs tyrosine kinases TAM, qui comprend Tyro3, Axl et Mer. Ces récepteurs sont impliqués dans la régulation des réponses immunitaires, la survie cellulaire et l'élimination des cellules apoptotiques. La dérégulation des récepteurs TAM est impliquée dans le cancer, les maladies auto-immunes et l'inflammation chronique. Chez CymitQuimica, nous proposons des inhibiteurs des récepteurs TAM pour soutenir vos recherches en immunologie, oncologie et inflammation.
Produits appartenant à la catégorie "Récepteur TAM"
Trier par
DS-1205
CAS :DS-1205: AXL kinase inhibitor (IC50=1.3 nM), also targets MER, MET, TRKA (IC50s: 63, 104, 407 nM), hinders cell migration and tumor growth.Formule :C41H42FN5O7Degré de pureté :99.28%Couleur et forme :SolidMasse moléculaire :735.8TAM-IN-2
CAS :TAM-IN-2 is an inhibitor of TAM.Formule :C31H27F2N7O3Degré de pureté :98.09% - 99.74%Couleur et forme :SolidMasse moléculaire :583.59UNC2541
CAS :UNC2541 is a potent and Mer tyrosine kinase (MerTK)-specific inhibitor.Formule :C24H34FN7O2Degré de pureté :98.33%Couleur et forme :SolidMasse moléculaire :471.57UNC569
CAS :UNC569 selectively inhibits kidney URAT1, regulating uric acid excretion and aiding gout patient's uric balance.Formule :C22H29FN6Degré de pureté :98.91%Couleur et forme :SolidMasse moléculaire :396.5Ref: TM-T21302
1mg46,00€2mg59,00€5mg87,00€10mg144,00€25mg311,00€50mg512,00€100mg730,00€1mL*10mM (DMSO)96,00€Ningetinib
CAS :Ningetinib (CT-053) (CT053PTSA) is an orally bioavailable tyrosine kinase inhibitor with IC50s of <1.0, 1.9 and 6.7 nM for Axl, VEGFR2, and c-Met, respectively.Formule :C31H29FN4O5Degré de pureté :99.77% - 99.95%Couleur et forme :SolidMasse moléculaire :556.58Bemcentinib
CAS :Bemcentinib (R428) is a selective inhibitor of Axl (IC50: 14 nM) and has been investigated for the treatment of NSCLC.Formule :C30H34N8Degré de pureté :97% - 99.8%Couleur et forme :SolidMasse moléculaire :506.64Ref: TM-T6269
1mg40,00€2mg52,00€5mg87,00€10mg144,00€25mg212,00€50mg274,00€100mg465,00€200mg622,00€500mg948,00€RU-302
CAS :RU-302 is a pan inhibitor of TAM Receptor blocking the interface between the TAM Ig1 ectodomain and the Gas6 Lg domain.Formule :C24H24F3N3O2SDegré de pureté :99.45%Couleur et forme :SolidMasse moléculaire :475.53Ref: TM-T16806
1mg43,00€5mg96,00€10mg150,00€25mg259,00€50mg374,00€100mg545,00€200mg740,00€1mL*10mM (DMSO)96,00€AXL-IN-15
CAS :AXL-IN-15 (cpd391) is a potent inhibitor of Axl, exhibiting both a dissociation constant (K i) and a half-maximal inhibitory concentration (IC50) of less than 1Formule :C26H32F3N9O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :575.59MerTK/Axl-IN-1
CAS :MerTK/Axl-IN-1 (Compound A-910) is a potent and selective dual inhibitor of MerTK/Axl, exhibiting IC50 values of 4.2 nM and 8.8 nM in Ba/F3 cells, and 0.2 nM and 0.9 nM in HTRF cells, respectively. It effectively inhibits pMerTK in vivo and possesses a long half-life and high oral bioavailability.Formule :C40H47FN6O4Couleur et forme :SolidMasse moléculaire :694.84BMS 777607
CAS :BMS 777607 (BMS 817378) is a Met-related inhibitor for c-Met/Axl/Ron/Tyro3. BMS-777607 has been investigated for the basic science of Malignant Solid Tumour.Formule :C25H19ClF2N4O4Degré de pureté :100% - 99.89%Couleur et forme :SolidMasse moléculaire :512.89Ref: TM-T2699
1mg35,00€5mg79,00€10mg124,00€25mg217,00€50mg359,00€100mg533,00€500mg1.169,00€1mL*10mM (DMSO)92,00€UNC 569 hydrochloride
UNC 569 hydrochloride: reversible ATP-competitive Mer inhibitor, IC50 2.9 nM, Ki 4.3 nM, also inhibits Axl/Tyro3; used in leukemia, teratoid tumor studies.Formule :C22H30ClFN6Degré de pureté :100%Couleur et forme :SolidMasse moléculaire :432.96SGI-7079
CAS :SGI-7079: selective Axl inhibitor; hinders tumor growth dose-dependently; may target EGFR inhibitor resistance.Formule :C26H26FN7Degré de pureté :95.05% - 99.26%Couleur et forme :SolidMasse moléculaire :455.53Ref: TM-T6982
2mg42,00€5mg62,00€10mg97,00€25mg188,00€50mg243,00€100mg354,00€500mg825,00€1mL*10mM (DMSO)67,00€XL092
CAS :XL092 (JUN04542) is an Axl Mer cMet KDR inhibitor for the treatment of Axl and Mer receptor tyrosine kinase- dependent disorders.Formule :C29H25FN4O5Degré de pureté :98.60%Couleur et forme :SolidMasse moléculaire :528.53LDC1267
CAS :LDC1267 is a excellently specific TAM(Tyro3, Axl and Mer) kinase inhibitor, for Mer( IC50<5 nM), Tyro3(IC50=8 nM), and Axl(IC50=29 nM).Formule :C30H26F2N4O5Degré de pureté :99.38% - 99.76%Couleur et forme :SolidMasse moléculaire :560.55Ref: TM-T2311
1mg35,00€2mg52,00€5mg77,00€10mg105,00€25mg168,00€50mg248,00€100mg419,00€1mL*10mM (DMSO)93,00€Dubermatinib
CAS :Dubermatinib (TP0903) is a potent and selective Axl kinase inhibitor.Formule :C24H30ClN7O2SDegré de pureté :98.65% - 98.92%Couleur et forme :SolidMasse moléculaire :516.06Ningetinib Tosylate
CAS :Ningetinib Tosylate is an orally bioavailable tyrosine kinase inhibitor with IC50s of <1.0, 1.9 and 6.7 nM for Axl, VEGFR2, and c-Met, respectively.Formule :C38H37FN4O8SDegré de pureté :99.93%Couleur et forme :SolidMasse moléculaire :728.79AXL-IN-14
CAS :AXL-IN-14: orally active, potent AXL inhibitor (IC50=0.8 nM); hinders Gas6/AXL migration, invasion; lowers p-AXL, p-AKT; anti-tumor.Formule :C32H24F2N4O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :566.55MerTK-IN-1
CAS :MerTK-IN-1 (compound 31) serves as an inhibitor of MerTK, with the capability to bind to the target in vivo.Formule :C23H26N8O4Couleur et forme :SolidMasse moléculaire :478.50Sitravatinib malate
CAS :Sitravatinib malate is an orally bioavailable receptor inhibitor of tyrosine kinase (RTK) (IC50s of 1.5 nM, 2 nM, 2 nM, 5 nM, 6 nM, 6 nM, 8 nM, 0.5 nM, 29 nM, 5Formule :C37H35F2N5O9SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :763.76UNC2881
CAS :UNC2881 is a specific Mer tyrosine kinase inhibitor (IC50: 4.3 nM). It is about 83- and 58-fold higher selectivity than Axl and Tyro3, respectively.Formule :C25H33N7O2Degré de pureté :98.97% - 99.74%Couleur et forme :SolidMasse moléculaire :463.58
